Adtran Holdings Inc Reports Results For The Quarter Ended September 30: Earnings Summary
ADTRAN Holdings Inc reports results for the quarter ended September 30 - Earnings Summary
ADTRAN Holdings Inc ADTN.OQ reported quarterly adjusted earnings of 9 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 5 cents. The mean expectation of six analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from 2 cents to 6 cents per share.
Revenue rose 0.6% to $281.17 million from a year ago; analysts expected $285.72 million.
ADTRAN Holdings Inc's reported EPS for the quarter was a loss of 10 cents.
ADTRAN Holdings Inc shares had fallen by 4.5% this quarter and lost 24.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 40.3% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the communications & networking peer group is also "buy"
Wall Street's median 12-month price target for ADTRAN Holdings Inc is $14.45, about 56.6% above its last closing price of $6.28
This summary was machine generated from LSEG data November 3 at 03:19 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | 0.03 | 0.09 | Beat |
Jun. 30 2026 | 0.10 | 0.04 | Missed |
Mar. 31 2026 | 0.09 | 0.14 | Beat |
Dec. 31 2025 | 0.08 | 0.16 | Beat |
Recent news on Adtran Holdings
See all newsUS RESEARCH ROUNDUP-Amgen, Carmax, Pfizer
Adtran Holdings Inc Reports Results For The Quarter Ended September 30: Earnings Summary
ADTRAN Q3 revenue misses on supply constraints
Brief: ADTRAN Q3 Adjusted EPS USD 0.09 Vs. IBES Estimate USD 0.03
Brief: Adtran Holdings, Inc. Appoints Dr. Christian H. Terlinde To Board Of Directors